New Delhi, 5 March 2024: The Delhi High Court has barred Natco Pharma from manufacturing and selling cancer drug Olaparib either under the brand name ‘BRACANAT’ or under other brand names till further orders.

“…the defendant (Natco) is in fact ......
View Details

Related News

• Ayush ministry, Raj govt yet to act against firm selling homoeopathic ‘insulin' (16-06-2024)

---

• 50 हजार गोलियां सप्लाई का चार साल से फरार इनामी पकड़ा (16-06-2024)

---

• JP Nadda directs to upgrade drugs, medical devices to world-class (16-06-2024)

---

• Police, Drugs Control Department join hands to curb drug abuse in Coimbatore (15-06-2024)

---

• NPPA invokes Para 3 of DPCO to direct Macleods Pharma to supply anti-TB drug to CMSS (15-06-2024)

---

• US FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot (15-06-2024)

---

• DoP seeks report on drug misuse, eyes NDPS Act inclusion (15-06-2024)

---

• Kerala drugs control dept steps up case against Baba Ramdev (15-06-2024)

---

• Antibacterial agents in the clinical pipeline increased from 80 in 2021 to 97 in 2023: WHO (14-06-2024)

---

• ‘Indian medical devices industry set to grow $50 billion by 2030’ (14-06-2024)

---